statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma Biomica Presents Positive Clinical Data Update...

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Evogene Reports First Quarter 2024 Financial Results Evogene Reports First Quarter 2024 Financial Results PR Newswire REHOVOT, Israel, May 23, 2024 Conference call and webcast: today, May 23, 2024...

Evogene Reports First Quarter 2024 Financial Results

Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds Casterra Announces Additional Agreements with Seed Producers to Meet Existing...

Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds

Evogene Schedules First Quarter 2024 Financial Results Release Evogene Schedules First Quarter 2024 Financial Results Release PR Newswire REHOVOT, Israel, May 9, 2024 Zoom conference call scheduled...

Evogene Schedules First Quarter 2024 Financial Results Release

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting PR Newswire...

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.

Watchers	3,517
52-Wk Low	$0.4502
52-Wk High	$1.44

Volume	85,742.00
52-Wk High	$1.44
52-Wk Low	$0.4502

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.13	--	--	N/A
Q1'24	-$0.10	-$0.08	15.79%	BEAT
Q4'23	-$0.14	-$0.13	7.14%	BEAT
Q3'23	-$0.16	-$0.08	48.94%	BEAT
Q2'23	-$0.18	-$0.17	2.86%	BEAT

EVGN Evogene Ltd

About

Feed

News

Earnings

Fundamentals